These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28923387)

  • 1. Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor.
    Park DS; Jo E; Choi J; Lee M; Kim S; Kim HY; Nam J; Ahn S; Hwang JY; Windisch MP
    Eur J Med Chem; 2017 Nov; 140():65-73. PubMed ID: 28923387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
    Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
    Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions.
    Kim HY; Kong S; Oh S; Yang J; Jo E; Ko Y; Kim SH; Hwang JY; Song R; Windisch MP
    Antiviral Res; 2016 May; 129():39-46. PubMed ID: 26850830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors.
    Hwang JY; Kim HY; Jo S; Park E; Choi J; Kong S; Park DS; Heo JM; Lee JS; Ko Y; Choi I; Cechetto J; Kim J; Lee J; No Z; Windisch MP
    Eur J Med Chem; 2013; 70():315-25. PubMed ID: 24177358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.
    Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC
    ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.
    Lee M; Yang J; Jo E; Lee JY; Kim HY; Bartenschlager R; Shin EC; Bae YS; Windisch MP
    Sci Rep; 2017 Mar; 7():44676. PubMed ID: 28333153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.
    Zhang X; Zhang N; Chen G; Turpoff A; Ren H; Takasugi J; Morrill C; Zhu J; Li C; Lennox W; Paget S; Liu Y; Almstead N; Njoroge FG; Gu Z; Komatsu T; Clausen V; Espiritu C; Graci J; Colacino J; Lahser F; Risher N; Weetall M; Nomeir A; Karp GM
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3947-53. PubMed ID: 23683597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and structure-activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitors.
    Wang NY; Zuo WQ; Xu Y; Gao C; Zeng XX; Zhang LD; You XY; Peng CT; Shen Y; Yang SY; Wei YQ; Yu LT
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1581-8. PubMed ID: 24529869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus Assembly.
    Rolt A; Talley DC; Park SB; Hu Z; Dulcey A; Ma C; Irvin P; Leek M; Wang AQ; Stachulski AV; Xu X; Southall N; Ferrer M; Liang TJ; Marugan JJ
    J Med Chem; 2021 Jul; 64(13):9431-9443. PubMed ID: 34184537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors.
    He S; Jain P; Lin B; Ferrer M; Hu Z; Southall N; Hu X; Zheng W; Neuenswander B; Cho CH; Chen Y; Worlikar SA; Aubé J; Larock RC; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ
    ACS Comb Sci; 2015 Oct; 17(10):641-52. PubMed ID: 26332742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs.
    Matsuno K; Ueda Y; Fukuda M; Onoda K; Waki M; Ikeda M; Kato N; Miyachi H
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4276-80. PubMed ID: 25086684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication.
    Chen G; Ren H; Turpoff A; Arefolov A; Wilde R; Takasugi J; Khan A; Almstead N; Gu Z; Komatsu T; Freund C; Breslin J; Colacino J; Hedrick J; Weetall M; Karp GM
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3942-6. PubMed ID: 23683596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and evolution of aloperine derivatives as a new family of HCV inhibitors with novel mechanism.
    Zhang X; Lv XQ; Tang S; Mei L; Li YH; Zhang JP; Jiang JD; Peng ZG; Song DQ
    Eur J Med Chem; 2018 Jan; 143():1053-1065. PubMed ID: 29232582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anilinocoumarin derivatives as agents against hepatitis C virus by the induction of IFN-mediated antiviral responses.
    Peng HK; Chen WC; Lee JC; Yang SY; Tzeng CC; Lin YT; Yang SC
    Org Biomol Chem; 2013 Mar; 11(11):1858-66. PubMed ID: 23377187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of indole derivatives as novel hepatitis C virus inhibitors.
    Han Z; Liang X; Wang Y; Qing J; Cao L; Shang L; Yin Z
    Eur J Med Chem; 2016 Jun; 116():147-155. PubMed ID: 27061978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication.
    Keaney EP; Connolly M; Dobler M; Karki R; Honda A; Sokup S; Karur S; Britt S; Patnaik A; Raman P; Hamann LG; Wiedmann B; LaMarche MJ
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3714-8. PubMed ID: 25065492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus.
    Liu Y; Li J; Gu Y; Ma L; Cen S; Peng Z; Hu L
    Eur J Med Chem; 2022 Jan; 228():114033. PubMed ID: 34883293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor.
    Hwang JY; Windisch MP; Jo S; Kim K; Kong S; Kim HC; Kim S; Kim H; Lee ME; Kim Y; Choi J; Park DS; Park E; Kwon J; Nam J; Ahn S; Cechetto J; Kim J; Liuzzi M; No Z; Lee J
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7297-301. PubMed ID: 23159569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors.
    Girijavallabhan VM; Alvarez C; Bennett F; Chen L; Gavalas S; Huang Y; Kim SH; Kosinski A; Pinto P; Rizvi R; Rossman R; Shankar B; Tong L; Velazquez F; Venkatraman S; Verma VA; Kozlowski J; Shih NY; Piwinski JJ; MacCoss M; Kwong CD; Bansal N; Clark JL; Fowler AT; Kezar HS; Valiyaveettil J; Reynolds RC; Maddry JA; Ananthan S; Secrist JA; Li C; Chase R; Curry S; Huang HC; Tong X; Njoroge FG; Arasappan A
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5652-7. PubMed ID: 22858143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2.
    Manvar D; Pelliccia S; La Regina G; Famiglini V; Coluccia A; Ruggieri A; Anticoli S; Lee JC; Basu A; Cevik O; Nencioni L; Palamara AT; Zamperini C; Botta M; Neyts J; Leyssen P; Kaushik-Basu N; Silvestri R
    Eur J Med Chem; 2015 Jan; 90():497-506. PubMed ID: 25483263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.